CTOs on the Move

Lifemark Health Group

www.lifemarkhealthgroup.ca

 
Lifemark Health Group is a diversified healthcare company in business since 1998 and has grown by acquisition over the past 13 years to include over 200 facilities across Canada.
  • Number of Employees: 1K-5K
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Avaxia Biologics

Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.

Strawn Arnold

Strawn Arnold & Associates, Ltd.. is a premier provider of executive search to the healthcare industry. Our reputation has been built through executing searches for directors of governance boards, all levels of general management, as well as selected functional experts. Many of our Partners are recognized as "best in class" in their market segments. With nearly four decades of service and experience, Strawn Arnold & Associates, Ltd. is unparalleled in the depth of its knowledge and understanding of the healthcare market. Our firm stands for results, integrity and personal service, while providing access to business leaders at the highest level across the industry.

Cardionomic

Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.

Business Dynamics Limited

Business Dynamics Limited is a Mineola, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Navicure

Navicure has chosen to focus exclusively on the needs of practices and institutions performing physician billing.